Evaluation of groups of drugs for pregnant women with bacterial vaginosis

bacterial vaginosis is currently one of the most common pathologies in pregnant women. It is during this period that the vaginal microflora undergoes a characteristic number of changes, which makes it the most vulnerable to opportunistic and pathogenic microorganisms. It became obvious that dysbiosis increases the risk of intrauterine infection of the fetus. This is a leading cause of early miscarriage, perinatal morbidity and mortality. In addition, it is known that the standard groups of drugs used in medical practice have certain harm to the fetus due to their high bioavailability and their ability to penetrate placental barriers quickly and well. Therefore, it is very important to choose an effective treatment strategy that simultaneously protects the woman's body from foreign bacteria, but does not harm the organogenesis of the fetus, especially in the first trimester of pregnancy. The treatment of pregnant women occupies a special niche in pharmacology. Therefore, we want to sanctify and select the most effective drugs with the least extensive side effects and teratogenic effects. This article will provide a comparative description of the drugs and suggest the most gentle and effective treatment tactics.

bacterial vaginosis, treatment of genital infections, taking medications during pregnancy, lincosamides, intravaginal suppositories, side effects, placental barrier